Titel

Merkliste
1 Ergebnisse

The thromboxane receptor antagonist NTP42 promotes benefici..:

Eamon P. Mulvaney ; Fabiana Renzo ; Rui Adão...
https://www.frontiersin.org/articles/10.3389/fcvm.2022.1063967/full. , 2022

Link: https://doi.org/10.3389/fcvm.2022.1063967

RT Journal
T1 <Title>The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:61ac0e73143f434fb6aee88b5fe3d60f&Exemplar=1&LAN=DE
				
A1 Eamon P. Mulvaney
A1 Fabiana Renzo
A1 Rui Adão
A1 Emilie Dupre
A1 Lucia Bialesova
A1 Viviana Salvatore
A1 Helen M. Reid
A1 Glória Conceição
A1 Julien Grynblat
A1 Aida Llucià-Valldeperas
A1 Jean-Baptiste Michel
A1 Carmen Brás-Silva
A1 Charles E. Laurent
A1 Luke S. Howard
A1 David Montani
A1 Marc Humbert
A1 Anton Vonk Noordegraaf
A1 Frédéric Perros
A1 Pedro Mendes-Ferreira
A1 B. Therese Kinsella
PB Frontiers Media S.A.
YR 2022
K1 pulmonary arterial hypertension (PAH)
K1 thromboxane receptor
K1 NTP42
K1 right ventricle (RV)
K1 heart failure
K1 Diseases of the circulatory (Cardiovascular) system
K1 RC666-701
JF https://www.frontiersin.org/articles/10.3389/fcvm.2022.1063967/full
LK http://dx.doi.org/https://doi.org/10.3389/fcvm.2022.1063967
DO https://doi.org/10.3389/fcvm.2022.1063967
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)